Advertisement
Screener

FORTREA HOLDINGS INC. (FTRE) Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent

FORTREA HOLDINGS INC. Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent

FORTREA HOLDINGS INC. (FTRE) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of -$1.10 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.

Financial Statements › Income Statement › Unrealized Gains

us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2026-07-29

  • FORTREA HOLDINGS INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-06-30 was -$1.10M, a 101.33% decline year-over-year.
  • FORTREA HOLDINGS INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-03-31 was -$25.40M, a 156.82% decline year-over-year.
  • FORTREA HOLDINGS INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-12-31 was $400.00K.
  • FORTREA HOLDINGS INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-09-30 was -$14.80M, a 120.87% decline year-over-year.
  • FORTREA HOLDINGS INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2025 was $112.90M.
  • FORTREA HOLDINGS INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2024 was -$67.40M, a 213.66% decline from fiscal 2023.
  • FORTREA HOLDINGS INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2023 was $59.30M.
  • FORTREA HOLDINGS INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2022 was -$126.70M.
Period endOther Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 monthOther Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month as first filedOther Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 monthOther Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 monthOther Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month as first filedOther Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 monthOther Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month as first filed
2026-06-30-$1.10M
10-Q · filed 2026-07-29
-$26.50M
10-Q · filed 2026-07-29
-$26.10M
derived: sum of 3 quarters · filed 2026-07-29
-$40.90M
derived: sum of 4 quarters · filed 2026-07-29
2026-03-31-$25.40M
10-Q · filed 2026-07-29
-$25.00M
derived: sum of 2 quarters · filed 2026-07-29
-$39.80M
derived: sum of 3 quarters · filed 2026-07-29
$42.80M
derived: sum of 4 quarters · filed 2026-07-29
2025-12-31$400.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
-$14.40M
derived: sum of 2 quarters · filed 2026-02-26
$68.20M
derived: sum of 3 quarters · filed 2026-07-29
$112.90M
10-K · filed 2026-02-26
2025-09-30-$14.80M
10-Q · filed 2025-11-05
$67.80M
derived: sum of 2 quarters · filed 2026-07-29
$112.50M
10-Q · filed 2025-11-05
$7.70M
derived: sum of 4 quarters · filed 2026-07-29
2025-06-30$82.60M
10-Q · filed 2026-07-29
$127.30M
10-Q · filed 2026-07-29
$22.50M
derived: sum of 3 quarters · filed 2026-07-29
$93.40M
derived: sum of 4 quarters · filed 2026-07-29
2025-03-31$44.70M
10-Q · filed 2026-07-29
-$60.10M
derived: sum of 2 quarters · filed 2026-07-29
$10.80M
derived: sum of 3 quarters · filed 2026-07-29
$3.40M
derived: sum of 4 quarters · filed 2026-07-29
2024-12-31-$104.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
-$33.90M
derived: sum of 2 quarters · filed 2026-02-26
-$41.30M
derived: sum of 3 quarters · filed 2026-02-26
-$67.40M
10-K · filed 2026-02-26
2024-09-30$70.90M
10-Q · filed 2025-11-05
$63.50M
derived: sum of 2 quarters · filed 2025-11-05
$37.40M
10-Q · filed 2025-11-05
$100.00M
derived: sum of 4 quarters · filed 2026-02-26
2024-06-30-$7.40M
10-Q · filed 2025-11-05
-$33.50M
10-Q · filed 2025-08-06
$29.10M
derived: sum of 3 quarters · filed 2026-02-26
-$25.30M
derived: sum of 4 quarters · filed 2026-02-26
2024-03-31-$26.10M
10-Q · filed 2025-11-05
$36.50M
derived: sum of 2 quarters · filed 2026-02-26
-$17.90M
derived: sum of 3 quarters · filed 2026-02-26
$14.10M
derived: sum of 4 quarters · filed 2026-02-26
2023-12-31$62.60M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$8.20M
derived: sum of 2 quarters · filed 2026-02-26
$40.20M
derived: sum of 3 quarters · filed 2026-02-26
$59.30M
10-K · filed 2026-02-26
$57.60M
10-K · filed 2024-03-13
2023-09-30-$54.40M
10-Q · filed 2024-11-08
-$54.80M
10-Q · filed 2023-11-13
-$22.40M
derived: sum of 2 quarters · filed 2024-11-08
-$3.30M
10-Q · filed 2024-11-08
-$4.30M
10-Q · filed 2023-11-13
$86.80M
derived: sum of 4 quarters · filed 2025-03-03
2023-06-30$32.00M
10-Q · filed 2024-11-08
$31.60M
10-Q · filed 2023-08-14
$51.10M
10-Q · filed 2024-08-12
$141.20M
derived: sum of 3 quarters · filed 2025-03-03
$44.60M
derived: sum of 4 quarters · filed 2025-03-03
2023-03-31$19.10M
10-Q · filed 2024-11-08
$18.90M
10-Q · filed 2023-08-14
$109.20M
derived: sum of 2 quarters · filed 2025-03-03
$12.60M
derived: sum of 3 quarters · filed 2025-03-03
-$73.00M
derived: sum of 4 quarters · filed 2025-03-03
2022-12-31$90.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03
-$6.50M
derived: sum of 2 quarters · filed 2025-03-03
-$92.10M
derived: sum of 3 quarters · filed 2025-03-03
-$126.70M
10-K · filed 2025-03-03
-$127.60M
10-K · filed 2024-03-13
2022-09-30-$96.60M
10-Q · filed 2023-11-13
-$182.20M
derived: sum of 2 quarters · filed 2023-11-13
-$216.80M
10-Q · filed 2023-11-13
2022-06-30-$85.60M
10-Q · filed 2023-11-13
-$120.20M
derived: sum of 2 quarters · filed 2023-11-13
2022-03-31-$34.60M
10-Q · filed 2023-11-13
2021-12-31-$28.00M
10-K · filed 2024-03-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
Personalis, Inc. (PSNL)United States$1.769B-13.30
CASTLE BIOSCIENCES INC (CSTL)United States$1.074B-37.45
Lumexa Imaging Holdings, Inc. (LMRI)United States$0.951B
CareDx, Inc. (CDNA)United States$3.174B13.21
Fulgent Genetics, Inc. (FLGT)United States$0.593B-6.70
BIODESIX INC (BDSX)United States$0.312B
EXAGEN INC. (XGN)United States$0.212B-5.95
Freenome, Inc. (FRNM)United States$0.143B
SERA PROGNOSTICS, INC. (SERA)United States$0.062B-5.75
AMERICAN SHARED HOSPITAL SERVICES (AMS)United States$0.010B-5.64